Biofrontera (BFRIW) Total Liabilities (2020 - 2025)

Biofrontera's Total Liabilities history runs 6 years deep, the most recent figure standing at $18.1 million for Q4 2025.

• In Q4 2025, Total Liabilities rose 2.35% year-over-year to $18.1 million; the TTM figure through Dec 2025 stood at $18.1 million (up 2.35% YoY), while the FY2025 annual figure was $18.1 million, up 2.35% from the prior year.
• Total Liabilities was $18.1 million for Q4 2025 at Biofrontera, roughly flat from $18.0 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $41.9 million in Q4 2021 to a low of -$7.2 million in Q2 2023.
• Historically, Total Liabilities has averaged $21.0 million across 5 years, with a median of $24.0 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Total Liabilities jumped 2560.31% in 2022, then tumbled 119.71% in 2023.
• A 5-year view of Total Liabilities shows it stood at $41.9 million in 2021, then plunged by 35.52% to $27.0 million in 2022, then declined by 14.32% to $23.1 million in 2023, then fell by 23.64% to $17.7 million in 2024, then climbed by 2.35% to $18.1 million in 2025.
• The last three Total Liabilities figures came in at $18.1 million (Q4 2025), $18.0 million (Q3 2025), and $24.8 million (Q2 2025), per Business Quant data.